Status:
COMPLETED
Prevention of Post-Operative Shivering
Lead Sponsor:
Cairo University
Conditions:
Post-Operative Shivering
Eligibility:
All Genders
18-40 years
Phase:
EARLY_PHASE1
Brief Summary
Shivering and vasoconstriction are thermoregulatory mechanisms that are required to increase core body temperature (BT) in patients with core hypothermia. paracetamol is an antipyretic drug that has ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Adult patients between 18-40 years.
- ASA physical status I and II
- Both genders
- Patients scheduled for elective mega-liposuction surgery under combined general epidural anesthesia
- Exclusion criteria
- Patients who refused to participate in the study,
- ASA physical status more than II,
- any contraindications to regional anesthesia,
- surgical duration less than two hours or exceeding six hours,
- giving history of any of the following; allergy to the study medications used, system impairment, alcohol abuse, any endocrine disease affecting body temperature such as thyroid disorders,
- any psychiatric or neurological disorders, convulsions, patient receiving vasodilators or medications likely to alter thermoregulation,
- Finally if their body temperature was recorded to surpass 37.5ºC or \<36.5°C before enrolment.
Exclusion
Key Trial Info
Start Date :
January 6 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 22 2022
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04682743
Start Date
January 6 2021
End Date
February 22 2022
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo university
Cairo, Egypt, 11562